Nuclear Safeguards Bill

Debate between Simon Hoare and Patricia Gibson

2nd reading: House of Commons
Monday 16th October 2017 Commons Chamber

[Simon Hoare]

I agree very much with my hon. Friend. It certainly shoots the fox that we will have a bonfire of regulations and a race to the bottom. I find it strange that those who have spoken against the Bill this evening have, in one breath, accused the Government of presiding over a chaotic, shambolic and uncontrolled, if not incontinent, Brexit process and have then chastised the Government for trying to ensure continuity at an early stage, as my hon. Friend and others have said. Such continuity is welcome, and we would be right to chastise the Government were we not to have it.

If the Bill is not a debate about Brexit virility, it is also certainly not about access to isotopes, and I absolutely deplore those who have tried to wave that shroud. One of my hon. Friends—I was going to say it was my hon. Friend the Member for Eastleigh (Mims Davies), but I do not think it was her—said that access to isotopes is important for a large number of our constituents who need them for medical treatment when they are unwell, and it is the worst kind of shroud waving to say that they will not have that access.

[Patricia Gibson]

The hon. Gentleman criticises those who have raised concerns about access to medical isotopes, who were echoing the medical experts in the field. Is he dismissing the legitimate concerns raised by those working in the medical field?

[Simon Hoare]

The hon. Lady falls into a classic trap. I am not one who seeks to dismiss experts—as a non-expert, I always turn to experts for advice—but a concern that is wrong in fact does not become legitimate if it is raised by an expert. A person could be concerned about all sorts of things, and they could have as many letters after their name as they like, but they are not always correct. Some Opposition Members started to fan the embers of this flame about three or four months ago, and it does not appear to have caught.

I have received a briefing note, as I am sure have other colleagues, entitled “What about medical radioisotopes?” The import or export of medical radioisotopes is not subject to any Euratom licensing requirements. Let us seek to assure the experts who have concerns—their concerns are legitimate, and the House must address them—that Euratom places no restrictions on the export of medical isotopes to countries outside the EU. These isotopes are not subject to Euratom supply agency contracts or to Euratom safeguards, which means no special arrangements need to be put in place ahead of withdrawal.

Withdrawal from Euratom will have no effect on the UK’s ability to import medical isotopes from Europe and the rest of the world. It is in everyone’s interest not to disrupt patients’ timely access to treatment, and it is in everyone’s interest to ensure that cross-border trade with the EU is as frictionless as possible. I entirely take the point raised by several hon. Members, including the hon. Member for Inverness, Nairn, Badenoch and Strathspey (Drew Hendry), that some of these products have a short shelf life, and clearly we cannot have these products sitting in an overheated metal container at the port of Dover or Calais.

Out of common sense I have to ask which country on God’s earth will set a tariff barrier regime and seek to take beyond its useful lifespan a vital component in the delivery of medical care. In the French Government, the German Government and the Belgian Government, we are not dealing with countries that have no interest in public health and healthcare, because of course they do, as do our Government. The idea that those countries will deliberately set up barriers that cause these products to pass their sell-by date, like a piece of chicken that has been sat too long on a supermarket shelf, is fanciful and compounds the allegation that I and several of my hon. Friends have made, that the Bill can be criticised for other reasons, but it is cruel, callous and unnecessary to criticise it at the expense of unsettling people who require medical interventions.

--- Later in debate ---

[Simon Hoare]

I apologise for seeking to remake this point for the convenience of the hon. Gentleman, Madam Deputy Speaker, but I am simply saying this: irrespective of how we might have campaigned and voted in the referendum, this is a time when we have a responsibility, as parliamentarians, to make sure that on certain key things—something as sensitive as this is a key thing—we set aside our personal beefs on whether it is a good or bad idea, in order to make sure our constituents are not alarmed. We have heard from the Secretary of State, read the briefing papers and heard from the Universities Minister, as my hon. Friend the Member for Bury St Edmunds (Jo Churchill) has pointed out, and that should now shoot that fox well and truly. What has been suggested is not going to be a by-product of coming out of Euratom.

[Patricia Gibson]

I just want to clarify this point, and I assure the hon. Gentleman that I will not try to intervene again, because I am sure he will answer it well, and I hope he understands that I have enormous respect for him. I understand that he has a background in public relations, so given his background and level of expertise in his field, is he comfortable with contradicting and dismissing as “scaremongering”, “overreacting” or whatever word he wants to use, the legitimate concerns raised by the Royal College of Radiologists?

[Simon Hoare]

I am not contradicting. I am seeking to answer—

--- Later in debate ---

[Simon Hoare]

My hon. Friend gets the point, because he takes a Conservative approach to the operation of the economy. People in Britain want to buy something. We do not make it, but some countries overseas do. But we have also heard this, “We make too much for our domestic market and we want to sell it overseas. We have been doing this for years, but, do you know what? Just to bite off our nose to spite our face, we’ll stop doing it.” That is the crux of the argument we have heard from the hon. Members for North Ayrshire and Arran and for Kilmarnock and Loudoun (Alan Brown). I would say it was bizarre if it were not so careless.

Let me conclude my remarks by returning to the point about the value—soft as well as hard—to UK plc of the collaborative opportunities for research that membership of an organisation such as Euratom presents. We have heard from my right hon. Friend the Member for Wantage (Mr Vaizey), my hon. Friend the Member for Copeland (Trudy Harrison) and the hon. Member for Barrow and Furness (John Woodcock) about the supply chain, the jobs and the offshoots of economic activity that flow from this. If we are talking about background research, I understand that the hon. Member for North Ayrshire and Arran has a nuclear facility in her constituency. One can only presume that she has constituents who work in it, but she said precious little about them in her speech—

[Patricia Gibson]

That was not in the scope of the Bill.

[Simon Hoare]

Well, that did not stop the hon. Lady dilating on lots of other things that were not in the Bill. This sudden stricture of rectitude and probity that she cloaks herself in as the winter months approach is a little hard to take. We should never underestimate what that collaborative research does to advance the sum of human knowledge, and to benefit our country in hard currency terms and profile terms as a centre of excellence, expertise, professionalism and world leadership. I see this Bill as very much taking a belt-and-braces approach. I just hope that if we have to default to this, because we find that the lawyers are right or we are not allowed to remain part of Euratom as there is some conflict with the European Court of Justice or whatever, the regimes we put in place and the culture we create tell the rest of the world interested in this sector that we, too, are open for business and committed to research, and we are not turning our back on academic and, yes, medical collaboration.